ZEVRA THERAPEUTICS, INC. - Common Stock (ZVRA)
CUSIP: 488445206
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 56,066,823
- Total 13F shares
- 16,043,055
- Share change
- +1,987,107
- Total reported value
- $78,561,424
- Put/Call ratio
- 23%
- Price per share
- $4.90
- Number of holders
- 92
- Value change
- +$9,453,621
- Number of buys
- 53
- Number of sells
- 26
Quarterly Holders Quick Answers
What is CUSIP 488445206?
CUSIP 488445206 identifies ZVRA - ZEVRA THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 488445206:
Top shareholders of ZVRA - ZEVRA THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Samuel J. Braun |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,153,000
|
$15,636,043 | — | 13 May 2021 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
4.4%
|
2,453,405
|
$14,229,749 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.3%
|
2,397,847
|
$13,907,513 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3%
|
1,704,006
|
$9,883,235 | — | 31 Mar 2024 | |
| Woodline Partners LP |
13F
|
Company |
1.8%
|
1,009,617
|
$5,855,779 | — | 31 Mar 2024 | |
| 683 Capital Management, LLC |
13F
|
Company |
1.4%
|
800,000
|
$4,640,000 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
787,020
|
$4,565,174 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
1.2%
|
683,172
|
$3,962,398 | — | 31 Mar 2024 | |
| Janney Montgomery Scott LLC |
13F
|
Company |
1.2%
|
660,169
|
$3,829,000 | — | 31 Mar 2024 | |
| Retirement Planning Co of New England, Inc. |
13F
|
Company |
0.77%
|
430,193
|
$2,495,119 | — | 31 Mar 2024 | |
| Altium Capital Management LLC |
13F
|
Company |
0.61%
|
341,461
|
$1,980,474 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.53%
|
297,067
|
$1,722,988 | — | 31 Mar 2024 | |
| Mystic Asset Management, Inc. |
13F
|
Company |
0.47%
|
266,297
|
$1,544,523 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.36%
|
199,268
|
$1,155,756 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.28%
|
155,400
|
$901,000 | — | 31 Mar 2024 | |
| Travis C. Mickle |
3/4/5
|
President & CEO, Director |
—
class O/S missing
|
171,774
|
$851,845 | — | 25 May 2022 | |
| Kovack Advisors, Inc. |
13F
|
Company |
0.25%
|
141,846
|
$822,707 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.23%
|
129,730
|
$752,434 | — | 31 Mar 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.23%
|
129,189
|
$749,296 | — | 31 Mar 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.17%
|
95,143
|
$551,829 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.16%
|
91,410
|
$530,178 | — | 31 Mar 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.16%
|
90,802
|
$526,652 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.16%
|
90,127
|
$522,736 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.16%
|
88,609
|
$513,932 | — | 31 Mar 2024 | |
| Arete Wealth Advisors, LLC |
13F
|
Company |
0.14%
|
79,104
|
$458,803 | — | 31 Mar 2024 | |
| Stratos Wealth Partners, LTD. |
13F
|
Company |
0.13%
|
70,240
|
$407,392 | — | 31 Mar 2024 | |
| Sven Guenther |
3/4/5
|
Chief Scientific Officer |
—
class O/S missing
|
79,000
|
$391,769 | — | 31 Jan 2024 | |
| Christal M. M. Mickle |
3/4/5
|
Chief Development Officer |
—
class O/S missing
|
77,000
|
$381,851 | — | 31 Jan 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.09%
|
48,255
|
$279,873 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.08%
|
42,948
|
$249,098 | — | 31 Mar 2024 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.06%
|
35,466
|
$205,000 | — | 31 Mar 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.06%
|
34,707
|
$201,301 | — | 31 Mar 2024 | |
| STRS OHIO |
13F
|
Company |
0.06%
|
30,900
|
$179,000 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.05%
|
25,944
|
$150,475 | — | 31 Mar 2024 | |
| Raymond James Financial Services Advisors, Inc. |
13F
|
Company |
0.05%
|
25,756
|
$149,385 | — | 31 Mar 2024 | |
| Richard W. Pascoe |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
29,973
|
$148,639 | — | 09 Mar 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.05%
|
25,606
|
$148,515 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.04%
|
23,908
|
$138,666 | — | 31 Mar 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.04%
|
22,332
|
$129,526 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.04%
|
20,760
|
$120,408 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.04%
|
20,025
|
$116,145 | — | 31 Mar 2024 | |
| IFG Advisors, LLC |
13F
|
Company |
0.03%
|
18,700
|
$108,460 | — | 31 Mar 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.03%
|
18,159
|
$105,322 | — | 31 Mar 2024 | |
| Palumbo Wealth Management LLC |
13F
|
Company |
0.03%
|
18,088
|
$104,911 | — | 31 Mar 2024 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.03%
|
17,923
|
$103,953 | — | 31 Mar 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.03%
|
17,623
|
$102,213 | — | 31 Mar 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.03%
|
16,964
|
$98,391 | — | 31 Mar 2024 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.03%
|
16,121
|
$93,502 | — | 31 Mar 2024 | |
| LPL Financial LLC |
13F
|
Company |
0.03%
|
16,057
|
$93,131 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.03%
|
15,919
|
$92,330 | — | 31 Mar 2024 |
Institutional Holders of ZEVRA THERAPEUTICS, INC. - Common Stock (ZVRA) as of Q2 2024
As of 30 Jun 2024,
ZEVRA THERAPEUTICS, INC. - Common Stock (ZVRA) was held by
92 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,043,055 shares.
The largest 10 holders included
BlackRock Inc., Nantahala Capital Management, LLC, VANGUARD GROUP INC, Altium Capital Management LP, Woodline Partners LP, GEODE CAPITAL MANAGEMENT, LLC, 683 Capital Management, LLC, STATE STREET CORP, Retirement Planning Co of New England, Inc., and Janney Montgomery Scott LLC.
This page lists
92
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
88
Q2 2024 holders
92
Holder diff
4
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.